Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression
YL-109 inhibits cell growth and metastatic potential by inducing CHIP expression through AhR signaling and reduces cancer stem cell properties in MDA-MB-231 cells
Animal tests using human tumour xenograft models demonstrates that E7070 can cause not only tumour growth suppression
CAS Number: 209984-68-9
InChi: InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61
2B-(SP) (TFA) Size:Contact [email protected] for quotation Oral administration of I-BET726 to2B (SP) TFA is a eIF2B based substrate for glycogen synthase kinase 3 (GSK 3). 2B (SP) TFA is readily phosphorylated by both the and isoforms of GSK 3. Product information Molecular Weight: 1949. 89 Formula: C73H124F3N26O31P Chemical Name: 2 [[5 amino 2 [[1 [2 [[2 [2 [[2 [[2 [[2 [[2 [[2 [[2 [2 [2 [[2 [(2 amino 5 carbamimidamidopentanoyl)amino] 5 carbamimidamidopentanoyl]amino]propanoylamino]propanoylamino] 4 carboxybutanoyl]amino] 4
US$ 85.00
US$ 98.00
US$ 38.00
US$ 38.00
US$ 69.95
US$ 18.00
US$ 110.00
US$ 70.00
US$ 49.00
US$ 98.00
US$ 54.00